Oppenheimer Raises Price Target Following Honeywell's (HON) 2016 Outlook

Market Wrap: Fed Hikes Rates; Valeant Trims Outlook; BATS to Try Another IPO; Industrial Production Lagged in Nov.

Market wrap for December 16th

End of the Day: S&P 500 up 29.7 to 2,073.07; Dow Jones up 224.2 to 17,749.09; Nasdaq up 75.8 to 5,071.13

Market Brief: The Fed raised its rates by 0.25 points, as anticipated following the October meeting. Markets ran higher following the announcement.

Housing starts outpaced in November, while industrial production fell more than expected for the month.

Valeant cut FY16 expectations amid Philidor debacle, new Walgreens agreement

BATS Global Markets is trying for an IPO once again.

Hilton may... More

Honeywell (HON) Issues Strong FY16 EPS, Revenue Outlook

Honeywell (NYSE: HON) announced its 2016 financial forecast and reaffirmed its 2015 earnings outlook reflected below:

2016 Guidance

2015 Guidance

2016 Guidance

Changevs.... More

Honeywell (HON) Completes Acquisition of Sigma-Aldrich's Lab Research Chemicals Business

Honeywell (NYSE: HON) announced that it has completed the acquisition of the Seelze, Germany-based laboratory research chemicals business from Sigma-Aldrich, broadening Honeywell's offerings for high-purity solutions for drug discovery, medical diagnostic testing and other laboratory applications.

The acquisition includes the Fluka-branded solvents and inorganic chemistry portfolio worldwide and the Sigma-Aldrich-branded solvents and inorganic chemistry portfolio in the European Economic Area (EEA). Those offerings are now part of Honeywell's broader portfolio of offerings for research chemicals, which already includes the Riedel-de Haën® and Burdick & Jackson® brands.

"The combined Honeywell business will be able to serve a... More